Neurogene Inc. - Common Stock (NGNE)

Historical Holders from Q4 2023 to Q3 2025

Symbol
NGNE on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
15,392,157
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
15,298,947
Holdings value
$265,156,048
% of all portfolios
0.001%
Number of holders
87
Number of buys
38
Number of sells
-36
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Neurogene Inc. - Common Stock (NGNE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.99% $23,096,955 1,498,829 RTW Investments, LP 31 Dec 2024
Redmile Group, LLC 9.9% $22,803,194 1,479,766 Redmile Group, LLC 31 Dec 2024
EcoR1 Capital, LLC 9.9% $25,005,492 1,442,902 EcoR1 Capital, LLC 30 Sep 2025
Casdin Capital, LLC 8.7% $19,961,513 1,295,361 Casdin Capital, LLC 31 Dec 2024
BlackRock, Inc. 6.8% $15,586,229 1,011,436 BlackRock, Inc. 31 Mar 2025
BAKER BROS. ADVISORS LP 7% -29.6% $21,254,360 -$10,597,328 991,804 -33.3% Julian C. Baker 30 Jun 2025
Trails Edge Capital Partners, LP 5.1% $20,794,650 785,000 Trails Edge Capital Partners, LP 08 Dec 2025
FMR LLC 3.1% $7,132,965 462,879 FMR LLC 31 Mar 2025
GREAT POINT PARTNERS LLC 2.98% $6,822,947 442,761 Great Point Partners, LLC 31 Dec 2024
Commodore Capital LP 3% $9,169,168 427,866 Commodore Capital LP 30 Jun 2025

Institutional Holders of Neurogene Inc. - Common Stock (NGNE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 15,298,947 $265,156,048 -$165,308 $17.33 87
2025 Q2 15,388,370 $230,113,281 -$13,642,147 $14.95 81
2025 Q1 16,456,922 $192,796,009 +$733,702 $11.71 83
2024 Q4 16,089,357 $367,798,856 +$14,465,324 $22.86 86
2024 Q3 13,847,659 $581,113,931 +$18,023,436 $41.96 85
2024 Q2 13,265,527 $482,740,723 +$37,443,874 $36.39 66
2024 Q1 12,128,797 $617,303,585 +$152,848,957 $50.9 58
2023 Q4 9,233,865 $178,953,482 +$178,848,733 $19.38 35